Epsilon M&A Deal Report - Orthoway (Cellier Orthopédie & Orthofiga)
Transaction Multiples for the Valuation of Private Companies
Ossur / Orthoway (Cellier Orthopédie & Orthofiga)
No EMAT :
121605
Announced Date :
30/12/2020
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Ossur
Target :
Orthoway (Cellier Orthopédie & Orthofiga)
Country :
France
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Implants or Prostheses Manufacturers
Business Description :
Founded in 2017 through the merger of Cellier Orthopédie and Orthofiga, Orthoway is the 4th largest player in the French external orthopaedics market. > The group specializes in orthopaedic care and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Implants or Prostheses Manufacturers » = 65
| Date | Acquirer | Target | Country | Multiples | See details |
| 31/03/2023 | Sartorius Stedim Biotech | Polyplus Transfection (PolygenX A) | France | * | 121592 |
| 08/03/2023 | Eqwal | Steeper | United Kingdom | ** | 121572 |
Source: Epsilon Research / EMAT
